Intra-Cellular Therapies' Caplyta shows strong sales growth and label expansion potential, making it a valuable acquisition for Johnson & Johnson ... sales growth and no signs of slowing down.

After watching the four-plus minute video Johnson was in tears on set as his co-hosts showered him with praise for his incredible life. "That's the first time I've ever seen that," said Johnson.